170 related articles for article (PubMed ID: 35660740)
1. The immuno-behavioural covariation associated with the treatment response to bumetanide in young children with autism spectrum disorder.
Li Q; Zhang L; Shan H; Yu J; Dai Y; He H; Li WG; Langley C; Sahakian BJ; Yao Y; Luo Q; Li F
Transl Psychiatry; 2022 Jun; 12(1):228. PubMed ID: 35660740
[TBL] [Abstract][Full Text] [Related]
2. Improved symptoms following bumetanide treatment in children aged 3-6 years with autism spectrum disorder: a randomized, double-blind, placebo-controlled trial.
Dai Y; Zhang L; Yu J; Zhou X; He H; Ji Y; Wang K; Du X; Liu X; Tang Y; Deng S; Langley C; Li WG; Zhang J; Feng J; Sahakian BJ; Luo Q; Li F
Sci Bull (Beijing); 2021 Aug; 66(15):1591-1598. PubMed ID: 36654288
[TBL] [Abstract][Full Text] [Related]
3. Bumetanide, a Diuretic That Can Help Children with Autism Spectrum Disorder.
Shaker E; El Agami O; Salamah A
CNS Neurol Disord Drug Targets; 2024; 23(4):536-542. PubMed ID: 37021422
[TBL] [Abstract][Full Text] [Related]
4. Symptom improvement in children with autism spectrum disorder following bumetanide administration is associated with decreased GABA/glutamate ratios.
Zhang L; Huang CC; Dai Y; Luo Q; Ji Y; Wang K; Deng S; Yu J; Xu M; Du X; Tang Y; Shen C; Feng J; Sahakian BJ; Lin CP; Li F
Transl Psychiatry; 2020 Jan; 10(1):9. PubMed ID: 32066666
[TBL] [Abstract][Full Text] [Related]
5. Bumetanide for Autism Spectrum Disorder in Children: A Review of Randomized Controlled Trials.
James BJ; Gales MA; Gales BJ
Ann Pharmacother; 2019 May; 53(5):537-544. PubMed ID: 30501497
[TBL] [Abstract][Full Text] [Related]
6. A randomised controlled trial of bumetanide in the treatment of autism in children.
Lemonnier E; Degrez C; Phelep M; Tyzio R; Josse F; Grandgeorge M; Hadjikhani N; Ben-Ari Y
Transl Psychiatry; 2012 Dec; 2(12):e202. PubMed ID: 23233021
[TBL] [Abstract][Full Text] [Related]
7. Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders.
Lemonnier E; Villeneuve N; Sonie S; Serret S; Rosier A; Roue M; Brosset P; Viellard M; Bernoux D; Rondeau S; Thummler S; Ravel D; Ben-Ari Y
Transl Psychiatry; 2017 Mar; 7(3):e1056. PubMed ID: 28291262
[TBL] [Abstract][Full Text] [Related]
8. Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials).
Crutel V; Lambert E; Penelaud PF; Albarrán Severo C; Fuentes J; Rosier A; Hervás A; Marret S; Oliveira G; Parellada M; Kyaga S; Gouttefangeas S; Bertrand M; Ravel D; Falissard B
J Autism Dev Disord; 2021 Aug; 51(8):2959-2972. PubMed ID: 33151500
[TBL] [Abstract][Full Text] [Related]
9. Successive clinical application of vitamin D and bumetanide in children with autism spectrum disorder: A case report.
Feng JY; Li HH; Wang B; Shan L; Jia FY
Medicine (Baltimore); 2020 Jan; 99(2):e18661. PubMed ID: 31914053
[TBL] [Abstract][Full Text] [Related]
10. A Pilot Study on the Combination of Applied Behavior Analysis and Bumetanide Treatment for Children with Autism.
Du L; Shan L; Wang B; Li H; Xu Z; Staal WG; Jia F
J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):585-8. PubMed ID: 26258842
[TBL] [Abstract][Full Text] [Related]
11. Bumetanide in the management of autism. Tunisian experience in Razi Hospital.
Hajri M; Ben Amor A; Abbes Z; Dhouib S; Ouanes S; Mrabet A; Daghfous R; Bouden A
Tunis Med; 2019; 97(8-9):971-977. PubMed ID: 32173844
[TBL] [Abstract][Full Text] [Related]
12. Bumetanide oral solution for the treatment of children and adolescents with autism spectrum disorder: Results from two randomized phase III studies.
Fuentes J; Parellada M; Georgoula C; Oliveira G; Marret S; Crutel V; Albarran C; Lambert E; Pénélaud PF; Ravel D; Ben Ari Y
Autism Res; 2023 Oct; 16(10):2021-2034. PubMed ID: 37794745
[TBL] [Abstract][Full Text] [Related]
13. Bumetanide for autism: Open-label trial in six children.
Fernell E; Gustafsson P; Gillberg C
Acta Paediatr; 2021 May; 110(5):1548-1553. PubMed ID: 33336381
[TBL] [Abstract][Full Text] [Related]
14. Effects of Bumetanide on Neurocognitive Functioning in Children with Autism Spectrum Disorder: Secondary Analysis of a Randomized Placebo-Controlled Trial.
van Andel DM; Sprengers JJ; Königs M; de Jonge MV; Bruining H
J Autism Dev Disord; 2024 Mar; 54(3):894-904. PubMed ID: 36626004
[TBL] [Abstract][Full Text] [Related]
15. Treating Autism With Bumetanide: Are Large Multicentric and Monocentric Trials on Selected Populations Complementary?
Lemonnier E; Rabiei H; Makowski D; Hadjikhani N; Ben-Ari Y
J Am Acad Child Adolesc Psychiatry; 2021 Aug; 60(8):937-938. PubMed ID: 33385505
[TBL] [Abstract][Full Text] [Related]
16. A Phase III Study of Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents Aged Between 7 and 17 Years with Autism Spectrum Disorder (SIGN 1 Trial): Participant Baseline Characteristics.
Georgoula C; Ferrin M; Pietraszczyk-Kedziora B; Hervas A; Marret S; Oliveira G; Rosier A; Crutel V; Besse E; Severo CA; Ravel D; Fuentes J
Child Psychiatry Hum Dev; 2023 Oct; 54(5):1360-1372. PubMed ID: 35292925
[TBL] [Abstract][Full Text] [Related]
17. Dr. Sprengers et al. Reply.
Sprengers JJ; van Andel DM; Bruining H
J Am Acad Child Adolesc Psychiatry; 2021 Aug; 60(8):938-939. PubMed ID: 33450401
[TBL] [Abstract][Full Text] [Related]
18. Mood Stabilizers in Children and Adolescents With Autism Spectrum Disorders.
Canitano R
Clin Neuropharmacol; 2015; 38(5):177-82. PubMed ID: 26366961
[TBL] [Abstract][Full Text] [Related]
19. Treatment Effect of Bumetanide in Children With Autism Spectrum Disorder: A Systematic Review and Meta-Analysis.
Wang T; Shan L; Miao C; Xu Z; Jia F
Front Psychiatry; 2021; 12():751575. PubMed ID: 34867539
[No Abstract] [Full Text] [Related]
20. Bumetanide for Core Symptoms of Autism Spectrum Disorder (BAMBI): A Single Center, Double-Blinded, Participant-Randomized, Placebo-Controlled, Phase-2 Superiority Trial.
Sprengers JJ; van Andel DM; Zuithoff NPA; Keijzer-Veen MG; Schulp AJA; Scheepers FE; Lilien MR; Oranje B; Bruining H
J Am Acad Child Adolesc Psychiatry; 2021 Jul; 60(7):865-876. PubMed ID: 32730977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
